FDA Issues Long-Overdue Regulations on Direct-To-Consumer Advertisements for Prescription Medications

Start
On November 21, 2023, the FDA published its final rule changing how prescriptions medicines are advertised to consumers. The FDA first issued its proposed rule in 2010, which subsequently went through three public comment periods between 2010 and 2012. Interestingly, the FDA provided no opportunities for the public to comment on the rule since 2012….
By: Knobbe Martens
Previous Story

The Data Act – the EU’s bid to “ensure fairness in the digital environment and a competitive data market” – has been adopted

Next Story

New York Aims to Bolster Hospital Cybersecurity with Imminent Release of Proposed Regulations